STAT+: Pharmalittle: Canada OKs ALS drug still waiting FDA approval; WTO talks on Covid patent waiver are down to the wire
At a WTO conference on a response to the pandemic, the issue generating the most debate is a highly controversial proposal to temporarily waive intellectual property rights for vaccines.
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because the oh-so-familiar routine
